EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Approaches and Innovations in Managing Preeclampsia: Highlighting Maternal Health Disparities

Alexis G Dickerson, Christiana A Joseph iD, Khosrow Kashfi iD

Journal of Clinical Medicine · 11.02.2025 · 14 (4) · 1190

DOI: 10.3390/jcm14041190 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.02.2025. Verfasst von Alexis G Dickerson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular, Cellular, and Biomedical Sciences, Sophie Davis School of Biomedical Education, City University of New York School of Medici…. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIMHD NIH HHS, National Institute of Health, USA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Preeclampsia (PE) is a major cause of maternal mortality and morbidity, affecting 3–6% of pregnancies worldwide and ranking among the top six causes of maternal deaths in the U.S. PE typically develops after 20 weeks of gestation and is characterized by new-onset hypertension and/or end-organ dysfunction, with or without proteinuria. Current management strategies for PE emphasize early diagnosis, blood pressure control, and timely delivery. For prevention, low-dose aspirin (81 mg/day) is recommended for high-risk women between 12 and 28 weeks of gestation. Magnesium sulfate is also advised to prevent seizures in preeclamptic women at risk of eclampsia. Emerging management approaches include antiangiogenic therapies, hypoxia-inducible factor suppression, statins, and supplementation with CoQ10, nitric oxide, and hydrogen sulfide donors. Black women are at particularly high risk for PE, potentially due to higher rates of hypertension and cholesterol, compounded by healthcare disparities and possible genetic factors, such as the APOL1 gene. This review explores current and emerging strategies for managing PE and addresses the underlying causes of health disparities, offering potential solutions to improve outcomes.

Schlagwörter

Stichwörter der Autor:innen

aspirincarbon monoxidehydrogen sulfidematernal mortalitynitric oxidepreeclampsiapregnancyracial disparitiesstatins

Autor:innen und Institutionen

  • Department of Molecular, Cellular, and Biomedical Sciences, Sophie Davis School of Biomedical Education, City University of New York School of Medicine, New York, NY 10031, USA.
  • Department of Chemistry and Physics, State University of New York at Old Westbury, Old Westbury, NY 11568, USA.
  • Graduate Program in Biology, City University of New York Graduate Center, New York, NY 10091, USA.

ORCID-Profile: Christiana A Joseph, Khosrow Kashfi

Förderung

  • NIGMS NIH HHS
  • NIMHD NIH HHS
  • National Institute of Health, USA
  • National Institutes of Health, USA

Zitieren

APA

Dickerson, A. G., Joseph, C. A., & Kashfi, K. (2025). Current Approaches and Innovations in Managing Preeclampsia: Highlighting Maternal Health Disparities. Journal of Clinical Medicine, 14(4), 1190. https://doi.org/10.3390/jcm14041190

Vancouver

Dickerson AG, Joseph CA, Kashfi K. Current Approaches and Innovations in Managing Preeclampsia: Highlighting Maternal Health Disparities. Journal of Clinical Medicine. 2025;14(4):1190. doi:10.3390/jcm14041190

BibTeX
@article{Dickerson2025,
  author = {Dickerson, Alexis G and Joseph, Christiana A and Kashfi, Khosrow},
  title = {Current Approaches and Innovations in Managing Preeclampsia: Highlighting Maternal Health Disparities},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {4},
  pages = {1190},
  doi = {10.3390/jcm14041190}
}
Kostenlos starten →